AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- The treatment landscape for early-stage triple-negative breast cancer (TNBC) continues to evolve with evidence from ongoing neoadjuvant and adjuvant therapy trials. A major development was the KEYNOTE-522 trial that established...
Source
MedPage Today
Opens original article in a new tab
In this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.
(MedPage Today) -- A hospital policy of giving high transfusion-risk patients tranexamic acid for noncardiac surgery reduced blood transfusions without increasing thromboembolic risk, the TRACTION randomized trial showed. Hospitals giving tranexamic...
(MedPage Today) -- Despite being more commonly diagnosed in women ages 40 or younger, an estimated 10% to 15% of early triple-negative breast cancer (TNBC) cases are diagnosed in patients over 70. Current guidelines recommend the use of adjuvant...
The American College of Obstetricians and Gynecologists has released a recommended vaccine schedule during pregnancy, one that diverges from CDC guidance.
